Search Within

Lisa Bodei

  1. "2018"
Formats
  1. Meeting Abstract (20)
  2. Journal Article (11)
  3. Book Section (2)
Groups
  1. Molecular Imaging and Therapy Service (33)
  2. Radiology, Department of (33)
  3. Sloan Kettering Institute Postdocs (33)
  4. Center for Pancreatic Cancer Research (3)
  5. Department of Medicine (3)
  6. Gastrointestinal Oncology Service (3)

More Groups

People
  1. Diane Reidy (3)
  2. Joseph O'Donoghue (2)
  3. Neeta Pandit-Taskar (2)
  4. Simone Krebs (2)
  5. Wolfgang Weber (2)
  6. Adam Kesner (1)

More People

Years
  1. 2018 (33)
Publications
  1. European Journal of Nuclear Medicine and Molecular Imaging (9)
  2. Neuroendocrinology (6)
  3. Pancreas (6)
  4. Journal of Clinical Oncology (2)
  5. Journal of Nuclear Medicine (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. Springer (10)
  2. Lippincott Williams & Wilkins (6)
  3. S. Karger AG (6)
  4. American Society of Clinical Oncology (2)
  5. Elsevier Inc. (2)
  6. Oxford University Press (2)

More Publishers

Results (33)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lanreotide depot/autogel before, during, and after peptide receptor radionuclide therapy (PRRT) in advanced neuroendocrine tumors (NETs): Data from the PRELUDE study
    Meeting Abstract

    Prasad, V.; Srirajaskanthan, R.; Toumpanakis, C.; Grana, C. M.; Baldari, S.; Shah, T.; Lamarca, A.; Courbon, F.; Scheidhauer, K.; Baudin, E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Peptide receptor radionuclide therapy (PRRT) transcriptomic signature in blood for prediction of (177)Lu-octreotate efficacy
    Meeting Abstract

    Bodei, L.; Kidd, M. S.; Singh, A.; van der Zwan, W. A.; Severi, S.; Drozdov, I.; Cwikla, J. B.; Baum, R. P.; Kwekkeboom, D. J.; Paganelli, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Neuroendocrine gene transcripts: The role of molecular biomarkers in diagnosis and management
    Book Section

    Bodei, L.; Kidd, M.; Chung, K. M.; Modlin, I.
    In Giovanella, L. (Eds.) Atlas of Thyroid and Neuroendocrine Tumor Markers (2018)

    Fulltext@MSK | Save
  • The molecular biology of NET: Current status and evaluation of biomarkers for prediction and prognosis
    Book Section

    Kidd, M.; Ferone, D.; Albertelli, M.; Nazzari, E.; Bodei, L.; Modlin, I. M.
    In Colao, A.; Faggiano, A.; de Herder, W. (Eds.) Neurodendocrine Tumors in Real Life: From Practice to Knowledge (2018)

    Fulltext@MSK | Save
  • Tumour growth rate (TGR) when using lanreotide Autogel® (LAN) before, during and after peptide receptor radionuclide therapy (PRRT) in advanced neuroendocrine tumours (NETs)
    Meeting Abstract

    Prasad, V.; Srirajaskanthan, R.; Grana, C. M.; Baldari, S.; Shah, T.; Lamarca, A.; Courbon, F.; Scheidhauer, K.; Baudin, E.; Truong-Thanh, X. M.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • The value of somatostatin receptor scintigraphy (SRS) in patients with NETG1/G2 neuroendocrine neoplasms of the small intestine (SI-NENs)
    Meeting Abstract

    Konsek, S. J.; Kolasinska-Cwikla, A. D.; Lewczuk, A.; Kidd, M.; Buscombe, J. R.; Bodei, L.; Cichocki, A.; Roszkowska-Purska, K.; Cwikla, J. B.; Modlin, I. M.
    European Journal of Nuclear Medicine and Molecular Imaging (2018)

    Fulltext@MSK | Save
  • Dosimetry of LUTATHERA in patients with advanced midgut neuroendocrine tumors: Results of the phase III NETTER-1 sub-study
    Meeting Abstract

    Bodei, L.; Cremonesi, M.; Ferrari, M.; Krenning, E.; Sierra, M. L.; Erion, J. L.; Santoro, P.; Chicco, D.; Mariani, M. F.
    European Journal of Nuclear Medicine and Molecular Imaging (2018)

    Fulltext@MSK | Save
  • Combined 177Lu-DOTATATE and metronomic capecitabine in gastro-entero-pancreatic neuroendocrine tumors with high glucose metabolism: Preliminary data of a phase II prospective trial
    Meeting Abstract

    Paganelli, G.; Nicolini, S.; Grana, C. M.; Bodei, L.; Di Mauro, F.; Tardelli, E.; Monti, M.; Ferroni, F.; Caroli, P.; Ibrahim, T.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2018)

    Fulltext@MSK | Save
  • Comparison of (68)Ga-DOTA-JR11 PET/CT with (dosimetric) (177)Lu-DOTA-JR11 SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy
    Meeting Abstract

    Krebs, S.; O'Donoghue, J.; Biegel, E.; Beattie, B. J.; Reidy, D.; Bodei, L.; Weber, W. A.; Pandit-Taskar, N.
    European Journal of Nuclear Medicine and Molecular Imaging (2018)

    Fulltext@MSK | Save
  • Renal protection during LUTATHERA treatment using lysine and arginine solutions
    Meeting Abstract

    Bodei, L.; Cremonesi, M.; Ferrari, M.; Krenning, E.; Sierra, M. L.; Erion, J. L.; Santoro, P.; Chicco, D.; Mariani, M. F.
    European Journal of Nuclear Medicine and Molecular Imaging (2018)

    Fulltext@MSK | Save